Welcome to Sathgen Therapeutics: Thank you for your interest in Sathgen Therapeutics, a biotech company dedicated to developing innovative cancer therapies.
Our Expertise: Sathgen Therapeutics has a state-of-the-art R&D facility and is actively involved in developing oncology therapeutics. Our lead compound, MSP008-22, has shown in vitro and in vivo efficacy against triple negative breast cancer and prostate cancer, and has an excellent safety profile. Our rich pipeline of over 15 compounds in preclinical development targets a variety of cancers.
Collaborating with Sathgen Therapeutics:
We are keen to collaborate with pharmaceutical companies to drive the development and commercialization of our drugs. We are open to discussing licensing agreements, research collaborations, or other forms of partnership to advance our shared goals of developing breakthrough therapies for cancer patients.
If you are interested in collaborating with Sathgen Therapeutics, please contact us to discuss potential opportunities.